Parnassus Investments LLC Buys 74 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Parnassus Investments LLC grew its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 11.1% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 738 shares of the pharmaceutical company’s stock after purchasing an additional 74 shares during the period. Parnassus Investments LLC’s […]

Related Keywords

Canada ,Brucei Sachs ,Carmen Bozic ,Piper Sandler ,William Blair ,News Ratings For Vertex Pharmaceuticals Daily ,Vanguard Group Inc ,Morgan Stanley ,Needham Company ,Wells Fargo Company ,Northern Trust Corp ,Vertex Pharmaceuticals Profile ,Quarter For Vertex Pharmaceuticals ,Vertex Pharmaceuticals Price Performance ,Vertex Pharmaceuticals ,Norges Bank ,Jennison Associates ,Securities Exchange Commission ,Vertex Pharmaceuticals Incorporated ,Exchange Commission ,Royal Bank ,Parnassus Investments ,Free Report ,Trust Corp ,Director Bruce ,Pharmaceuticals Incorporated ,Get Free Report ,Visit Holdingschannel ,Vertex Pharmaceuticals Daily ,